# Efficacy and Safety of BIO-K + CL1285 in Prevention of Antibiotic-associated Diarrhea in Hospitalized Adult Patients

> **NCT00328263** · PHASE3 · COMPLETED · sponsor: **Bio-K Plus International Inc.** · enrollment: 472 (actual)

## Conditions studied

- Diarrhea
- Clostridium Infections

## Interventions

- **DIETARY_SUPPLEMENT:** Lactobacillus acidophilus CL1285 and Lactobacillus casei
- **DIETARY_SUPPLEMENT:** placebo

## Key facts

- **NCT ID:** NCT00328263
- **Lead sponsor:** Bio-K Plus International Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2007-03
- **Final completion:** 2007-10
- **Target enrollment:** 472 (ACTUAL)
- **Last updated:** 2014-08-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00328263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00328263, "Efficacy and Safety of BIO-K + CL1285 in Prevention of Antibiotic-associated Diarrhea in Hospitalized Adult Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00328263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*